Mitochondrial ribosomal protein S18-2 evokes chromosomal instability and transforms primary rat skin fibroblasts

We have shown earlier that overexpression of the human mitochondrial ribosomal protein MRPS18-2 (S18-2) led to immortalization of primary rat embryonic fibroblasts. The derived cells expressed the embryonic stem cell markers, and cellular pathways that control cell proliferation, oxidative phosphorylation, cellular respiration, and other redox reactions were activated in the immortalized cells. Here we report that, upon overexpression of S18-2 protein, primary rat skin fibroblasts underwent cell transformation. Cells passed more than 300 population doublings, and two out of three tested clones gave rise to tumors in experimental animals. Transformed cells showed anchorage-independent growth and loss of contact inhibition; they expressed epithelial markers, such as E-cadherin and β-catenin. Transformed cells showed increased telomerase activity, disturbance of the cell cycle, and chromosomal instability. Taken together, our data suggest that S18-2 is a newly identified oncoprotein that may be involved in cancerogenesis.

[1]  G. Klein,et al.  Stem cell gene expression in MRPS18-2-immortalized rat embryonic fibroblasts , 2012, Cell Death and Disease.

[2]  W. Birchmeier,et al.  E‐cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming , 2011, EMBO reports.

[3]  H. Taniguchi,et al.  Evidence for Mesenchymal−Epithelial Transition Associated with Mouse Hepatic Stem Cell Differentiation , 2011, PloS one.

[4]  T. Rabbitts,et al.  Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer. , 2010, American journal of respiratory and critical care medicine.

[5]  J. Viola,et al.  Lipid droplets in inflammation and cancer. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[6]  J. C. Belmonte,et al.  Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2 , 2010, Nature Protocols.

[7]  L. Szekely,et al.  MRPS18–2 protein immortalizes primary rat embryonic fibroblasts and endows them with stem cell-like properties , 2009, Proceedings of the National Academy of Sciences.

[8]  A. Regev,et al.  SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas , 2009, Nature Genetics.

[9]  Alessandra Giorgetti,et al.  Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. , 2009, Cell stem cell.

[10]  B. Qian,et al.  Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II. , 2009, European journal of cancer.

[11]  P. Knoepfler,et al.  N-Myc Regulates Expression of Pluripotency Genes in Neuroblastoma Including lif, klf2, klf4, and lin28b , 2009, PloS one.

[12]  Hui Li,et al.  Generation of induced pluripotent stem cell lines from adult rat cells. , 2009, Cell stem cell.

[13]  Wenjun Guo,et al.  Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 , 2008, Nature Biotechnology.

[14]  Robert A. Weinberg,et al.  Ras oncogenes: split personalities , 2008, Nature Reviews Molecular Cell Biology.

[15]  Shi V. Liu.  iPS cells: a more critical review. , 2008, Stem cells and development.

[16]  L. Szekely,et al.  EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes , 2008, Proceedings of the National Academy of Sciences.

[17]  J. Viola,et al.  Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. , 2008, Cancer research.

[18]  Marius Wernig,et al.  c-Myc is dispensable for direct reprogramming of mouse fibroblasts. , 2008, Cell stem cell.

[19]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[20]  Marius Wernig,et al.  Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells , 2007, Nature Biotechnology.

[21]  R. Jaenisch,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.

[22]  A. Dvorak,et al.  Roles and origins of leukocyte lipid bodies: proteomic and ultrastructural studies , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  L. Szekely,et al.  SPR-based immunocapture approach to creating an interfacial sensing architecture: mapping of the MRS18-2 binding site on retinoblastoma protein , 2006, Analytical and bioanalytical chemistry.

[24]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[25]  J. V. Moran,et al.  Multiple forms of genetic instability within a 2‐Mb chromosomal segment of 3q26.3–q27 are associated with development of esophageal adenocarcinoma , 2006, Genes, chromosomes & cancer.

[26]  Sarah B. Tegen,et al.  Activated Src abrogates the Myc requirement for the G0/G1 transition but not for the G1/S transition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. A. Collins,et al.  Karyotypic analysis of adult pluripotent stem cells. , 2005, Histology and histopathology.

[28]  Y. Ishikawa,et al.  EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12) , 2005, Genes, chromosomes & cancer.

[29]  Dong-Hua Yang,et al.  Temporally regulated expression of Lin-28 in diverse tissues of the developing mouse. , 2003, Gene expression patterns : GEP.

[30]  A. Dvorak,et al.  RNA is closely associated with human mast cell lipid bodies. , 2003, Histology and histopathology.

[31]  W. Mann,et al.  Investigations for Fine Mapping of Amplifications in Chromosome 3q26.3–28 Frequently Occurring in Squamous Cell Carcinomas of the Head and Neck , 2002, Oncology.

[32]  B. Wullich,et al.  Novel amplification unit at chromosome 3q25–q27 in human prostate cancer , 2000, The Prostate.

[33]  L. Hayflick,et al.  The illusion of cell immortality , 2000, British Journal of Cancer.

[34]  M. Hughson,et al.  Clear-cell and papillary carcinoma of the kidney: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization. , 1998, Cancer genetics and cytogenetics.

[35]  J. Sedivy,et al.  Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[36]  G. Landberg,et al.  Telomerase activity is associated with cell cycle deregulation in human breast cancer. , 1997, Cancer research.

[37]  E. Prochownik,et al.  c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells , 1988, Molecular and cellular biology.

[38]  Wen-Hwa Lee,et al.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.

[39]  R. Newbold,et al.  Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene , 1983, Nature.

[40]  N. Reich,et al.  Specific interaction of the SV40 T antigen-cellular p53 protein complex with SV40 DNA. , 1982, Virology.

[41]  E. Scolnick,et al.  Identification of a sarcoma virus-coded phosphoprotein in nonproducer cells transformed by Kirsten or Harvey murine sarcoma virus. , 1979, Virology.

[42]  R. Kirschstein,et al.  Induction of Malignancy in vitro in Newborn Hamster Kidney Tissue Infected with Simian Vacuolating Virus (SV40) , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[43]  A. Dvorak.  Mast cell secretory granules and lipid bodies contain the necessary machinery important for the in situ synthesis of proteins. , 2005, Chemical immunology and allergy.

[44]  G. Klein.  Perspectives in studies of human tumor viruses. , 2002, Frontiers in bioscience : a journal and virtual library.

[45]  F. Alt,et al.  Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. , 2001, Immunity.